Literature DB >> 1670907

Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.

B P Grubb1, P Temesy-Armos, H Hahn, L Elliott.   

Abstract

PURPOSE: Vasovagally mediated hypotension and bradycardia are believed to be common, but difficult to diagnose, causes of syncope. Upright tilt-table testing has been proposed as a possible way to test for vasovagal episodes. This study investigated the clinical utility of this technique in the evaluation and management of patients with syncope of unknown origin. PATIENTS AND METHODS: Twenty-five patients with recurrent unexplained syncope and six control subjects were evaluated by use of an upright tilt-table test for 30 minutes, with or without an infusion of isoproterenol (1 to 3 micrograms/minute given intravenously), in an attempt to provoke bradycardia, hypotension, or both. Of the 25 patients, there were 14 males and 11 females, with a mean age of 50 +/- 16 years. Six control patients with no history of syncope were also studied. All tilt-positive patients received therapy with either beta-blockers, disopyramide, transdermal scopolamine, or hydroflurocortisone, the efficacy of which was evaluated by another tilt-table test.
RESULTS: Syncope occurred in six patients (24%) during the baseline tilt and in nine patients (36%) during isoproterenol infusion (total positives, 60%). None of the controls had syncope during the test. All patients who had positive test results eventually became tilt-table-negative by therapy, and over a mean follow-up period of 16 +/- 2 months no further episodes have occurred.
CONCLUSION: From this study we conclude that upright tilt-table testing combined with isoproterenol infusion is clinically useful in the diagnosis of vasovagal syncope and the evaluation of pharmacologic therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670907     DOI: 10.1016/0002-9343(91)90499-n

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Forearm vascular responses during orthostatic stress in control subjects and patients with posturally related syncope.

Authors:  C M Brown; R Hainsworth
Journal:  Clin Auton Res       Date:  2000-04       Impact factor: 4.435

2.  Isoproterenol infusion provokes vasovagal response without upright tilt in a patient exhibiting syncopal episodes.

Authors:  M Shihara; Y Harasawa; S Ando; M Mohri; A Takeshita
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

3.  Good news--bad press: applied psychophysiology in cardiovascular disorders.

Authors:  A McGrady
Journal:  Biofeedback Self Regul       Date:  1996-12

4.  Tilt testing with combined lower body negative pressure: a "gold standard" for measuring orthostatic tolerance.

Authors:  Clare L Protheroe; Henrike Rianne J C Ravensbergen; Jessica A Inskip; Victoria E Claydon
Journal:  J Vis Exp       Date:  2013-03-21       Impact factor: 1.355

Review 5.  The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance.

Authors:  M Lamarre-Cliche; J Cusson
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

6.  Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome.

Authors:  F De Lorenzo; J Hargreaves; V V Kakkar
Journal:  Clin Auton Res       Date:  1997-08       Impact factor: 4.435

7.  Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation.

Authors:  A P Fitzpatrick; R J Lee; L M Epstein; M D Lesh; S Eisenberg; M M Sheinman
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

8.  Head-up tilt testing: the balance of evidence.

Authors:  C A Morillo; K A Ellenbogen; G J Klein
Journal:  Br Heart J       Date:  1995-06

9.  Hyporeninemic hypoaldosteronism complicating primary autonomic insufficiency.

Authors:  F I Polsky; D Roque; P E Hill
Journal:  West J Med       Date:  1993-08

10.  Head-up tilt test: a highly sensitive, specific test for children with unexplained syncope.

Authors:  D Alehan; A Celiker; S Ozme
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.